< Back to previous page
Researcher
Ingeborg Stalmans
- Disciplines:Ophthalmology, Neurosciences not elsewhere classified
Affiliations
- Research Group Ophthalmology (Division)
Responsible
From1 Jan 2017 → Today - Research Group Ophthalmology (Division)
Member
From27 Sep 2004 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 2 Mar 2002
Projects
1 - 10 of 26
- Principled Machine Learning for longitudinal biomedical data with repeated measuresFrom1 Feb 2024 → TodayFunding: BOF - doctoral mandates
- Multimodal imaging of retinal manifestations of Alzheimer’s disease for early diagnosis and clinical researchFrom1 Jan 2023 → TodayFunding: FWO fellowships
- High-intensity interval training in patients with glaucoma (HIT GLAUCOMA).From1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Multimodal imagiNg of rEtinal ManifestatiOns of Alzheimer’s diseaSe for earlY diagNosis and clinical rEsearch.From1 Oct 2022 → 31 Aug 2023Funding: BOF - postdoctoral mandates
- Hyperspectral retinal imaging as a novel biomarker for Alzheimer’s disease: towards a better understanding of the underlying pathological changesFrom26 Sep 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Validation and development of deep learning models for automated glaucoma detection and progression quantification using Tays Eye Centre dataFrom8 Nov 2021 → 7 Nov 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- The eye as a window to the brain: tackling neurodegenerative disordersFrom1 Nov 2021 → 31 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- The eye as a window to the brain: tackling neurodegenerative disorders.From1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The eye as a window to the brain: tackling neurodegenerative disordersFrom1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Worldwide Consortium of Retinal Imaging for Alzheimer's DiseaseFrom1 Jun 2021 → TodayFunding: FWO Strategic Basic Research (SBO)
Publications
1 - 10 of 213
- The effect of citicoline oral solution on quality of life in patients with glaucoma: the results of an international, multicenter, randomized, placebo-controlled cross-over trial(2023)
Authors: Ingeborg Stalmans, Evelien Vandewalle, Sophie Lemmens
Pages: 1659 - 1668 - Artificial Intelligence Software for Diabetic Eye Screening: Diagnostic Performance and Impact of Stratification(2023)
Authors: Freya Peeters, Ingeborg Stalmans, Julie Jacob
- Normal tension glaucoma: A dynamic optical coherence tomography angiography study(2023)
Authors: Jan Van Eijgen, Margaux Delporte, Dries De Witte, Geert Molenberghs, João Breda, Ingeborg Stalmans
- OCT biomarkers of neurodegenerative diseases – reading the tea leaves or seeing the truth?(2023)
Authors: Eirini Christinaki, Lies De Groef, Ingeborg Stalmans
Pages: 1 - 2 - The natural history of untreated ocular hypertension and glaucoma.(2023)
Authors: Ingeborg Stalmans
Pages: 388 - 424 - Glaucomatous optic neuropathy in relation to 24-h ambulatory blood pressure monitoring.(2022)
Authors: Ingeborg Stalmans, Zhenyu Zhang
Pages: e4 - Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure(2022)
Authors: Dongmei Wei, Thomas Vanassche, Peter Verhamme, Ingeborg Stalmans, Zhenyu Zhang
- Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study(2022)
Authors: Ingeborg Stalmans
Pages: 1399 - 1405 - Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel(2022)
Authors: Ingeborg Stalmans
Pages: 1743 - 1766 - Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous NFKB1 mutations(2022)
Authors: Frederik Staels, Emanuela Pasciuto, Eveline Lescrinier, Xavier Bossuyt, Margaux Gerbaux, Julika Neumann, Ingeborg Stalmans, Isabelle Meyts, Adrian Liston, Stephanie Humblet-Baron, et al.
Linked dataset
1 - 1 of 1